Seizure Engram
癫痫发作印迹
基本信息
- 批准号:10304392
- 负责人:
- 金额:$ 3.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-15 至 2021-10-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdverse effectsAffectAnimalsBehaviorBiologicalBrainBrain regionCellsChemicalsChimeric ProteinsChronicControl AnimalDiseaseElectric StimulationEngineeringEnterobacteria phage P1 Cre recombinaseEpilepsyExhibitsFOS geneFire - disastersFluorescenceFluorescence MicroscopyGene ExpressionGeneralized seizuresGenerationsGenesGeneticGenetic RecombinationGoalsHippocampus (Brain)HistologicImmediate-Early GenesInjectionsInterventionIntractable EpilepsyKnowledgeLabelLightLuciferasesMemoryMolecularMusNeuronsOperative Surgical ProceduresOpsinPatientsPentylenetetrazolePharmaceutical PreparationsPopulationPreventionProceduresProcessProteinsPumpReagentReporterRodentRodent ModelSeizuresStereotypingStructureSystemTamoxifenTechniquesTestingTimeTransgenic MiceViral Vectorbasebrain cellcell typecoelenterazinecomparative efficacydentate gyruseffective therapygranule cellinnovationmouse modelneuroregulationoptogeneticspreventpromotersuccesstool
项目摘要
PROJECT SUMMARY/ABSTRACT
Epileptic seizures can be characterized as concerted and synchronized activity of neurons across the brain for
an extended period of time. We hypothesize that, as for other normal brain-controlled behavior, epileptic seizures
are not caused by random activity of neurons, but rather arise from activity in a specific, organized brain network.
Our overarching goal is to elucidate such a seizure-specific network in the brain and to deliver genetic
neuromodulation specifically to such a seizure-generating network for tailored seizure suppression. In our
proposal, we first identify all the critical brain cells that make up that seizure network in acute and chronic rodent
models of epilepsy. Then, we will manipulate such a network to stop seizure occurrence.
We will identify and visualize brain structures and cells responsible for generation of seizures in the whole brain
by labeling these cells with a fluorescent protein tag utilizing sophisticated gene expression techniques in
genetically modified mice (Specific Aim 1). This seizure-specific labelling of neurons occurs when they exhibit
extensive activity in the presence of a chemical in the system during a seizure episode. This labelling procedure
will be repeated to examine if the same neuronal populations become active in two separate episodes of
seizures. The cells labeled with the fluorescence reporter will be examined by fluorescence microscopy.
Overlapped labelling of neurons between two seizure episodes will support our hypothesis that the same subset
of neurons is repeatedly involved in generation of seizures.
We will then employ a similar strategy to deliver genetic neuromodulation to a seizure-generating network
(Specific Aim 2). We engineered a viral vector that carries a molecular tool that suppress neuronal activity when
an activating drug is injected into the animal. This viral vector will be injected into a brain region responsible for
generation of seizures in the rodent models of epilepsy we will use. We expect that such manipulation will
suppress subsequent seizures.
Our hypothesis views and treats epileptic seizures as a network function in the brain. Together with robust
network-specific suppression of seizures in mouse models of epilepsy, this will change the way we view and
treat this disease.
项目总结/摘要
癫痫发作可以被表征为跨大脑的神经元的协调和同步活动,
很长一段时间我们假设,与其他正常的大脑控制行为一样,癫痫发作
不是由神经元的随机活动引起的,而是由特定的、有组织的大脑网络的活动引起的。
我们的首要目标是阐明大脑中这种特定的神经网络,并提供遗传学上的信息。
神经调节特异性地针对这样的用于定制的癫痫发作抑制的癫痫发生网络。在我们
我们首先在急性和慢性啮齿类动物中识别出构成癫痫网络的所有关键脑细胞。
癫痫模型然后,我们将操纵这样一个网络来阻止癫痫发作。
我们将识别和可视化大脑结构和细胞负责在整个大脑中产生癫痫发作
通过利用复杂的基因表达技术用荧光蛋白标记这些细胞,
转基因小鼠(具体目标1)。当神经元表现出
在癫痫发作期间,系统中存在化学物质时的广泛活动。这个标签程序
将被重复,以检查是否相同的神经元群体在两个单独的事件中变得活跃。
癫痫发作将通过荧光显微镜检查用荧光报告物标记的细胞。
两次癫痫发作之间神经元的重叠标记将支持我们的假设,即同一子集
神经元的分裂反复参与癫痫发作的发生。
然后,我们将采用类似的策略,将遗传神经调节传递给神经元生成网络
(具体目标2)。我们设计了一种病毒载体,它携带一种分子工具,当
将激活药物注射到动物体内。这种病毒载体将被注射到大脑中负责
在我们将使用的啮齿动物癫痫模型中产生癫痫发作。我们预计,这种操纵将
抑制随后的癫痫发作。
我们的假说认为癫痫发作是大脑中的一个网络功能。与鲁棒
网络特异性抑制癫痫小鼠模型中的癫痫发作,这将改变我们看待和
治疗这种疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT E GROSS其他文献
ROBERT E GROSS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT E GROSS', 18)}}的其他基金
Development and validation of a viral vector for targeted inhibition of DG granule cells
用于靶向抑制 DG 颗粒细胞的病毒载体的开发和验证
- 批准号:
10648833 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别:
Data-driven optimization for DBS programming in temporal lobe epilepsy
颞叶癫痫 DBS 编程的数据驱动优化
- 批准号:
10574839 - 财政年份:2022
- 资助金额:
$ 3.9万 - 项目类别:
Development of a self-regulated neuroprotective gene therapy for Parkinsons Disease and other synucleinopathies
开发针对帕金森病和其他突触核蛋白病的自我调节神经保护基因疗法
- 批准号:
9809188 - 财政年份:2019
- 资助金额:
$ 3.9万 - 项目类别:
C3 transferase Gene Therapy for CNS Axon Regeneration
用于中枢神经系统轴突再生的 C3 转移酶基因治疗
- 批准号:
8873702 - 财政年份:2015
- 资助金额:
$ 3.9万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 3.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 3.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 3.9万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 3.9万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 3.9万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 3.9万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 3.9万 - 项目类别:
Discovery Grants Program - Individual